These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

126 related articles for article (PubMed ID: 15190583)

  • 1. Bioinversion of R-flurbiprofen to S-flurbiprofen at various dose levels in rat, mouse, and monkey.
    Leipold DD; Kantoci D; Murray ED; Quiggle DD; Wechter WJ
    Chirality; 2004 Jul; 16(6):379-87. PubMed ID: 15190583
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Biliary excretion and enterohepatic cycling of R- and S-flurbiprofen in the rat.
    Eeckhoudt SL; Evrard PA; Verbeeck RK
    Drug Metab Dispos; 1997 Apr; 25(4):428-30. PubMed ID: 9107541
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Stereoselective pharmacokinetics of flurbiprofen in humans and rats.
    Jamali F; Berry BW; Tehrani MR; Russell AS
    J Pharm Sci; 1988 Aug; 77(8):666-9. PubMed ID: 3210154
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pharmacokinetics and synovial fluid concentrations of flurbiprofen enantiomers in horses: chiral inversion.
    Soraci AL; Tapia O; Garcia J
    J Vet Pharmacol Ther; 2005 Feb; 28(1):65-70. PubMed ID: 15720517
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Studies on the in vitro inversion of flurbiprofen.
    Lombard A; Rossetti V; Cassone MC
    Chirality; 1997; 9(3):317-9. PubMed ID: 9176999
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Mutual inversion of flurbiprofen enantiomers in various rat and mouse strains.
    de Bruin N; Ferreirós N; Schmidt M; Hofmann M; Angioni C; Geisslinger G; Parnham MJ
    Chirality; 2018 May; 30(5):632-641. PubMed ID: 29406583
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Does stereochemistry influence transdermal permeation of flurbiprofen through the rat skin?
    Valentová J; Bauerová K; Farah L; Devínsky F
    Arch Dermatol Res; 2010 Oct; 302(8):635-8. PubMed ID: 20582424
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Stereoselective disposition of tiaprofenic acid enantiomers in rats.
    Erb K; Brugger R; Williams K; Geisslinger G
    Chirality; 1999; 11(2):103-8. PubMed ID: 9951401
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Drug evaluation: (R)-flurbiprofen--an enantiomer of flurbiprofen for the treatment of Alzheimer's disease.
    Geerts H
    IDrugs; 2007 Feb; 10(2):121-33. PubMed ID: 17285465
    [TBL] [Abstract][Full Text] [Related]  

  • 10. HPLC microdetermination of flurbiprofen enantiomers in plasma with a glycopeptide-type chiral stationary phase column.
    Péhourcq F; Matoga M; Jarry C; Bannwarth B
    Biomed Chromatogr; 2004 Jun; 18(5):330-4. PubMed ID: 15236442
    [TBL] [Abstract][Full Text] [Related]  

  • 11. R-flurbiprofen: isomeric ballast or active entity of the racemic compound?
    Geisslinger G; Menzel-Soglowek S; Beck WS; Brune K
    Agents Actions Suppl; 1993; 44():31-6. PubMed ID: 8372732
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Safety, tolerability, pharmacokinetics, and Abeta levels after short-term administration of R-flurbiprofen in healthy elderly individuals.
    Galasko DR; Graff-Radford N; May S; Hendrix S; Cottrell BA; Sagi SA; Mather G; Laughlin M; Zavitz KH; Swabb E; Golde TE; Murphy MP; Koo EH
    Alzheimer Dis Assoc Disord; 2007; 21(4):292-9. PubMed ID: 18090435
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Dosage plan of a flurbiprofen injection product using inhibition of protein binding by lipid emulsion in rats.
    Ogata K; Takamura N; Tokunaga J; Kawai K; Arimori K; Higuchi S
    J Pharm Pharmacol; 2008 Jan; 60(1):15-20. PubMed ID: 18088500
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Inversion of (R)- to (S)-ketoprofen in eight animal species.
    Aberg G; Ciofalo VB; Pendleton RG; Ray G; Weddle D
    Chirality; 1995; 7(5):383-7. PubMed ID: 7495642
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Analysis of flurbiprofen, ketoprofen and etodolac enantiomers by pre-column derivatization RP-HPLC and application to drug-protein binding in human plasma.
    Jin YX; Tang YH; Zeng S
    J Pharm Biomed Anal; 2008 Apr; 46(5):953-8. PubMed ID: 18329215
    [TBL] [Abstract][Full Text] [Related]  

  • 16. S- but not R-enantiomers of flurbiprofen and ibuprofen reduce human microglial and THP-1 cell neurotoxicity.
    Klegeris A; Maguire J; McGeer PL
    J Neuroimmunol; 2004 Jul; 152(1-2):73-7. PubMed ID: 15223239
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Enantiomeric disposition of ketorolac in goats following administration of a single intravenous and oral dose.
    Nagilla R; Deshmukh DD; Copedge KJ; Miller S; Martin B; Bell EC; Duran SH; Ravis WR
    J Vet Pharmacol Ther; 2009 Feb; 32(1):49-55. PubMed ID: 19161455
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Stereoselective pharmacokinetics of flurbiprofen and formation of covalent adducts with plasma protein in adjuvant-induced arthritic rats.
    Nagao T; Tanino T; Iwaki M
    Chirality; 2003 May; 15(5):423-8. PubMed ID: 12692887
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Chiral pharmacokinetics of Rac-flurbiprofen and pharmacodynamics of anabolic bone response in the normal rat.
    Wechter WJ; Bigornia AE; Murray ED; Jee WS
    Chirality; 1994; 6(6):457-9. PubMed ID: 7946972
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Rac-flurbiprofen is more ulcerogenic than its (S)-enantiomer.
    Wechter WJ; Bigornia AE; Murray ED; Levine BH; Young JW
    Chirality; 1993; 5(7):492-4. PubMed ID: 8240924
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.